News Center
2022/03/01
The province's largest immune cell cryopreservation bank "Jiangsu Baize cells" settled in Changzhou
On the morning of February 28, Jiangsu Baize Cell Biotechnology Co., Ltd., jointly established by Shanghai Cell Therapy Group and Jiangsu Jiuzhou Investment Group, was officially opened. The cell cryopreservation bank with a total capacity of 300,000 copies settled in Changzhou, which is currently the largest immune cell cryopreservation base in the province.
2022/05/25
Recently, Wang Xiaodan, member of the party group and deputy director of Changzhou Development and Reform Commission, led the city and district major offices to the project site of Jiangsu Baize Cell Biotechnology R&D Center in Niutang Town to investigate the project construction and promotion work on the spot. Mayor Tang Feng and Deputy Mayor Zhou Xiaocheng of Niutang Town; Tang Shengjun, General Manager of Jiangsu Baize Cell Biotechnology Co., Ltd., Liu Xinyu, Executive General Manager, and Xia Yan, Assistant General Manager, participated in the investigation.
2022/06/17
Shanghai Cell Therapy Group Tanhua "2022 Top 100 Future Healthcare China Innovative Biomedical List"
On June 15, the 6th Future Medical Top 100 Conference kicked off online. At the meeting, the list of the "Top 100 Future Medical Treatments in 2022" was announced, and Shanghai Cell Therapy Group won the third place in the "China Innovative Biomedical List".
2022/06/06
The 2022 American Society of Clinical Oncology (ASCO) Annual Meeting will be held June 3-7, 2022 in Chicago, USA. At the meeting, Shanghai Cell Therapy Group (hereinafter referred to as the "Group") demonstrated the Phase I clinical safety and preliminary efficacy of aPD1-mesCAR-T cells in the treatment of malignant mesothelioma, demonstrating the breakthrough progress of CAR-T cell therapy in overcoming solid tumors.
2022/03/03
On March 3rd, the launching ceremony of decoration project of Shanghai Cell Therapy Group Nobel Prize Center (hereinafter referred to as "Nobel Prize Center") was successfully held in Anting. Qian Qijun, chairman of Shanghai Cell Therapy Group, Ding Na, President of Shanghai Cell Therapy Group, Wang Feng, general manager of Suzhou Gold Mantis Group 27 Branch, Lu Honglan, marketing director of Suzhou Gold Mantis Group, Zhou Guoqiang, deputy general manager of Suzhou Gold Mantis Group 27 Branch, came to the scene to send their best wishes for the start of the Nobel Prize activity center. This project creates high-end research and development and good living space for high-level talents of Shanghai Cell Therapy Group.
2022/02/12
Party Secretary of Shaoxing Municipal Party Committee visited Zhejiang Nano antibody production base and Zhejiang Cell Therapy Group for investigation and investigation
Contact Info
ADD: No. 9 Yanzheng West Avenue, Wujin District, Changzhou City, Jiangsu Province
Copyright© 2022 Jiangsu Baize Cell Biotechnology Co., Ltd Powered by www.300.cn This website already supports IPV6 Seo
Online Message